Annual CFI
-$32.63 M
-$166.12 M-124.44%
December 31, 2024
Summary
- As of February 26, 2025, TXG annual cash flow from investing activities is -$32.63 million, with the most recent change of -$166.12 million (-124.44%) on December 31, 2024.
- During the last 3 years, TXG annual CFI has risen by +$74.10 million (+69.43%).
- TXG annual CFI is now -124.44% below its all-time high of $133.49 million, reached on December 31, 2023.
Performance
TXG Cash From Investing Chart
Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
Highlights
High & Low
Earnings dates
Quarterly CFI
-$51.59 M
-$47.97 M-1325.98%
December 31, 2024
Summary
- As of February 26, 2025, TXG quarterly cash flow from investing activities is -$51.59 million, with the most recent change of -$47.97 million (-1325.98%) on December 31, 2024.
- Over the past year, TXG quarterly CFI has dropped by -$47.97 million (-1325.98%).
- TXG quarterly CFI is now -143.01% below its all-time high of $119.96 million, reached on March 31, 2023.
Performance
TXG Quarterly CFI Chart
Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
Highlights
High & Low
Earnings dates
TTM CFI
-$32.63 M
-$64.69 M-201.78%
December 31, 2024
Summary
- As of February 26, 2025, TXG TTM cash flow from investing activities is -$32.63 million, with the most recent change of -$64.69 million (-201.78%) on December 31, 2024.
- Over the past year, TXG TTM CFI has dropped by -$64.69 million (-201.78%).
- TXG TTM CFI is now -124.44% below its all-time high of $133.49 million, reached on December 31, 2023.
Performance
TXG TTM CFI Chart
Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
Highlights
High & Low
Earnings dates
Cash From Investing Formula
CFI = Cash Inflows from Investments − Cash Outflows for Investments
TXG Cash From Investing Trends
| PeriodPeriod | AnnualAnnual | QuarterlyQuarterly | TTMTTM |
|---|---|---|---|
| 1 y1 year | -124.4% | -1326.0% | -201.8% |
| 3 y3 years | +69.4% | -1326.0% | -201.8% |
| 5 y5 years | +23.7% | -1326.0% | -201.8% |
TXG Cash From Investing Highs & Lows
| PeriodPeriod | Annual vs highAnnual vs high | Annual vs lowAnnual vs low | Quarter. vs highQuarter. vs high | Quarter. vs lowQuarter. vs low | TTM vs highTTM vs high | TTM vs lowTTM vs low | |
|---|---|---|---|---|---|---|---|
| 3 y | 3-year | -124.4% | +90.7% | -143.0% | +80.0% | -124.4% | +90.7% |
| 5 y | 5-year | -124.4% | +90.7% | -143.0% | +80.0% | -124.4% | +90.7% |
| alltime | all time | -124.4% | +90.7% | -143.0% | +80.0% | -124.4% | +90.7% |
10x Genomics Cash From Investing History
| Date | Annual | Quarterly | TTM |
|---|---|---|---|
| Dec 2024 | -$32.63 M(-124.4%) | -$51.59 M(+1326.0%) | -$32.63 M(-201.8%) |
| Sep 2024 | - | -$3.62 M(-130.3%) | $32.06 M(-21.0%) |
| Jun 2024 | - | $11.95 M(+12.4%) | $40.58 M(+67.9%) |
| Mar 2024 | - | $10.63 M(-18.8%) | $24.17 M(-81.9%) |
| Dec 2023 | $133.49 M(-138.0%) | $13.10 M(+167.3%) | $133.49 M(+53.0%) |
| Sep 2023 | - | $4.90 M(-209.8%) | $87.22 M(+75.5%) |
| Jun 2023 | - | -$4.46 M(-103.7%) | $49.69 M(+86.6%) |
| Mar 2023 | - | $119.96 M(-461.6%) | $26.63 M(-107.6%) |
| Dec 2022 | -$350.89 M(+228.8%) | -$33.17 M(+1.7%) | -$350.89 M(+1.6%) |
| Sep 2022 | - | -$32.63 M(+18.5%) | -$345.33 M(+3.7%) |
| Jun 2022 | - | -$27.53 M(-89.3%) | -$332.93 M(+4.1%) |
| Mar 2022 | - | -$257.56 M(+832.6%) | -$319.97 M(+199.8%) |
| Dec 2021 | -$106.73 M | -$27.62 M(+36.5%) | -$106.73 M(+5.3%) |
| Date | Annual | Quarterly | TTM |
|---|---|---|---|
| Sep 2021 | - | -$20.23 M(+38.8%) | -$101.38 M(+22.9%) |
| Jun 2021 | - | -$14.57 M(-67.1%) | -$82.46 M(+10.5%) |
| Mar 2021 | - | -$44.32 M(+99.0%) | -$74.63 M(+94.4%) |
| Dec 2020 | -$38.39 M(-10.2%) | -$22.27 M(+1599.7%) | -$38.39 M(+69.1%) |
| Sep 2020 | - | -$1.31 M(-80.6%) | -$22.71 M(-35.3%) |
| Jun 2020 | - | -$6.74 M(-16.6%) | -$35.08 M(-15.4%) |
| Mar 2020 | - | -$8.08 M(+22.8%) | -$41.48 M(-3.0%) |
| Dec 2019 | -$42.77 M(+537.5%) | -$6.58 M(-51.9%) | -$42.77 M(+18.2%) |
| Sep 2019 | - | -$13.68 M(+4.1%) | -$36.19 M(+60.8%) |
| Jun 2019 | - | -$13.14 M(+40.3%) | -$22.51 M(+140.3%) |
| Mar 2019 | - | -$9.37 M | -$9.37 M |
| Dec 2018 | -$6.71 M(+78.6%) | - | - |
| Dec 2017 | -$3.76 M | - | - |
FAQ
- What is 10x Genomics annual cash flow from investing activities?
- What is the all time high annual CFI for 10x Genomics?
- What is 10x Genomics annual CFI year-on-year change?
- What is 10x Genomics quarterly cash flow from investing activities?
- What is the all time high quarterly CFI for 10x Genomics?
- What is 10x Genomics quarterly CFI year-on-year change?
- What is 10x Genomics TTM cash flow from investing activities?
- What is the all time high TTM CFI for 10x Genomics?
- What is 10x Genomics TTM CFI year-on-year change?
What is 10x Genomics annual cash flow from investing activities?
The current annual CFI of TXG is -$32.63 M
What is the all time high annual CFI for 10x Genomics?
10x Genomics all-time high annual cash flow from investing activities is $133.49 M
What is 10x Genomics annual CFI year-on-year change?
Over the past year, TXG annual cash flow from investing activities has changed by -$166.12 M (-124.44%)
What is 10x Genomics quarterly cash flow from investing activities?
The current quarterly CFI of TXG is -$51.59 M
What is the all time high quarterly CFI for 10x Genomics?
10x Genomics all-time high quarterly cash flow from investing activities is $119.96 M
What is 10x Genomics quarterly CFI year-on-year change?
Over the past year, TXG quarterly cash flow from investing activities has changed by -$47.97 M (-1325.98%)
What is 10x Genomics TTM cash flow from investing activities?
The current TTM CFI of TXG is -$32.63 M
What is the all time high TTM CFI for 10x Genomics?
10x Genomics all-time high TTM cash flow from investing activities is $133.49 M
What is 10x Genomics TTM CFI year-on-year change?
Over the past year, TXG TTM cash flow from investing activities has changed by -$64.69 M (-201.78%)